Form 8-K - Current report:
SEC Accession No. 0001437749-24-032612
Filing Date
2024-10-30
Accepted
2024-10-30 16:05:20
Documents
19
Period of Report
2024-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20241029_8k.htm   iXBRL 8-K 32894
2 LEGAL OPINION OF BAKER & HOSTETLER LLP ex_739811.htm EX-5.1 8933
3 FORM OF SECURITIES PURCHASE AGREEMENT, DATED OCTOBER 28, 2024, BY AND BETWEEN MO ex_739812.htm EX-10.1 204323
4 PLACEMENT AGENT AGREEMENT, DATED OCTOBER 28, 2024, BY AND BETWEEN MONOPAR THERAP ex_739817.htm EX-10.2 63417
5 EXHIBIT 99.1 ex_739700.htm EX-99.1 10591
10 monologo.jpg GRAPHIC 3641
  Complete submission text file 0001437749-24-032612.txt   540358

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20241028.xsd EX-101.SCH 3410
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20241028_def.xml EX-101.DEF 12188
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20241028_lab.xml EX-101.LAB 16397
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20241028_pre.xml EX-101.PRE 12458
21 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20241029_8k_htm.xml XML 3058
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 241410256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)